| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Rani Therapeutics Holdings, Inc. | General Counsel | Class A Common Stock | 163 K | $371 K | $2.27 | Mar 27, 2023 | Direct |
| Rani Therapeutics Holdings, Inc. | General Counsel | Stock Option (Right to Buy) | 324 K | Mar 21, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RANI | Rani Therapeutics Holdings, Inc. | Mar 21, 2024 | 1 | $0 | 4 | Mar 22, 2024 | General Counsel |
| RANI | Rani Therapeutics Holdings, Inc. | Dec 16, 2023 | 6 | $0 | 4 | Dec 19, 2023 | General Counsel |
| RANI | Rani Therapeutics Holdings, Inc. | Mar 27, 2023 | 2 | $0 | 4 | Mar 29, 2023 | GENERAL COUNSEL |
| RANI | Rani Therapeutics Holdings, Inc. | Mar 22, 2023 | 1 | -$14.9 K | 4 | Mar 24, 2023 | General Counsel |
| RANI | Rani Therapeutics Holdings, Inc. | Mar 22, 2022 | 2 | $0 | 4 | Mar 24, 2022 | General Counsel |
| RANI | Rani Therapeutics Holdings, Inc. | Mar 22, 2022 | 0 | $0 | 3 | Mar 24, 2022 | General Counsel |